Globus Medical (GMED) PT Lowered to $68 at Truist Securities Following EPS Miss
Tweet Send to a Friend
Truist Securities analyst Richard Newitter lowered the price target on Globus Medical (NYSE: GMED) to $68.00 (from $80.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
